Ministerial Ordinance on Good Clinical Practice for Drugs: Pharmaceuticals and Medical Devices Agency, Japan
The following English translations of Japanese ministerial ordnances are intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese originals and the translations, the former shall prevail. Provisional Translation (as of March 2013)∗
'Ministerial Ordinance on Good Clinical Practice for Drugs (as amended, effective December 28, 2012)', source: Pharmaceuticals and Medical Devices Agency, Japan.
Ministerial Ordinance on Good Clinical Practice for Drugs
Ordinance of the Ministry of Health and Welfare No. 28 of March 27, 1997
(As last amended by the Ordinance of Ministry of Health, Labour and Welfare No. 161 of December 28, 2012)
The Ministerial Ordinance on Good Clinical Practice (GCP) for Drugs shall be established as stated below in accordance with the following provisions of the Pharmaceutical Affairs Act (Act No. 145 of 1960): Article 14, Paragraph 3 (including cases where it shall apply mutatis mutandis in Article 14, Paragraph 6; Article 19-2, Paragraph 4; and Article 23 of the same Act),
Article 14-4, Paragraph 4, and Article 14-5, Paragraph 4 (including cases where these provisions shall apply mutatis mutandis in Article 19-4 and Article 23 of the same Act); Article 80-2, Paragraphs 1, 4 and 5; and Article 82.
Table of Contents
-
Chapter I. General Provisions (Articles 1 through 3)
-
Chapter II. Standards for Preparing Clinical Trials
-
Chapter III. Standards for Clinical Trial Management
-
Chapter IV. Standards for Conducting Clinical Trials
-
Chapter V. Standards for Documents Submitted in Reexamination etc. (Article 56)
-
Chapter VI. Standards for Sponsoring Clinical Trials etc. (Articles 57 through 59)
-
Supplementary Provisions
Disclamer: We take possible measures to ensure the accuracy of information published on this website, however, GCP Network will not assume any responsibility for any decisions/activities/actions which the user of our site performed by using any information published here.
Clinical Research News
Upcoming Clinical Research Events
-
29 September 2023 – 02 October 2024
SCDM (Society of Clinical Data Management)
United States -
11 – 12 December 2023
Informa
Online -
08 – 11 February 2024
AMIA (American Medical Informatics Association)
United States -
10 – 11 April 2024
The Society for Clinical Research Sites (SCRS)
United States -
16 – 18 April 2024
Informa
United States -
17 – 19 April 2024
SCDM (Society of Clinical Data Management)
Poland -
21 – 23 May 2024
Informa
Belgium -
03 – 04 June 2024
The Society for Clinical Research Sites (SCRS)
United States -
16 – 17 July 2024
The Society for Clinical Research Sites (SCRS)
Australia -
27 September – 29 October 2024
The Society for Clinical Research Sites (SCRS)
United States
Aankomende klinische onderzoeken
-
Apellis Pharmaceuticals, Inc.WervingGeografische atrofieVerenigde Staten
-
Karamanoğlu Mehmetbey UniversityWervingHospitalisme bij kinderenKalkoen
-
University of Wisconsin, MadisonNog niet aan het wervenPilot-effectiviteitsproef van een ACT-zelfhulpwerkboek, specifiek op maat gemaakt voor gevangenissenDepressie | Angst stoornissen | Ongerustheid | Depressie, angst
-
Assiut UniversityNog niet aan het wervenTrombocytopenie bij chronische nierziekte
-
Michigan State UniversityArizona State UniversityNog niet aan het wervenHPV-infectie | Door vaccinatie te voorkomen ziektenVerenigde Staten
-
Bitlis Eren UniversityNog niet aan het wervenErectiestoornissenKalkoen
-
Yisheng Biopharma (Singapore) Pte. Ltd.Nog niet aan het werven
-
University of PittsburghUnited States Agency for International Development (USAID); Oak Crest Institute...Nog niet aan het wervenVeiligheid | AanvaardbaarheidVerenigde Staten, Zuid-Afrika, Zimbabwe
-
Nationwide Children's HospitalRigel PharmaceuticalsNog niet aan het wervenAstrocytoom | Hooggradig glioom | Oligodendroglioom | Diffuus intrinsiek ponsglioom | Diffuus middellijnglioom, H3 K27M-mutant | WHO graad III glioom | Metastatische hersentumor | Spinale tumor | Astrocytoom, graad III | Astrocytoom, graad IV | IDH1-mutatie | WHO Graad IV Glioom | Thalamus-tumor | IDH1 R132 | IDH1 R132C en andere voorwaardenVerenigde Staten, Australië, Verenigd Koninkrijk, Canada, Duitsland, Nederland
-
Centre hospitalier de l'Université de Montréal...Optina Diagnostics Inc.WervingBijdrage van de kinematische theorie in de vroege differentiële diagnose van de ziekte van ParkinsonGezond | Ziekte van Parkinson | Parkinson-syndroomCanada
-
Renmin Hospital of Wuhan UniversityWerving
-
National Institute for Mother and Child Health...Marie Curie Emergency Children's Hospital, Bucharest; Victor Gomoiu Children's...WervingChronische granulomateuze ziekteRoemenië